121 related articles for article (PubMed ID: 7753461)
1. Alkalosis and hypomagnesaemia: unwanted effects of a low-calcium CAPD solution.
Tattersall JE; Dick C; Doyle S; Greenwood RN; Farrington K
Nephrol Dial Transplant; 1995; 10(2):258-62. PubMed ID: 7753461
[TBL] [Abstract][Full Text] [Related]
2. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
Bro S; Brandi L; Olgaard K
Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216
[TBL] [Abstract][Full Text] [Related]
3. Calcium, magnesium mass transfer and lactate balance study in CAPD patients with reduced calcium/magnesium and high lactate dialysis fluid.
Merchant MR; Hutchinson AJ; Butler SJ; Boulton H; Hintchliffe R; Gokal R
Adv Perit Dial; 1992; 8():365-8. PubMed ID: 1361824
[TBL] [Abstract][Full Text] [Related]
4. Hypercalcaemia, hypermagnesaemia, hyperphosphataemia and hyperaluminaemia in CAPD: improvement in serum biochemistry by reduction in dialysate calcium and magnesium concentrations.
Hutchison AJ; Were AJ; Boulton HF; Mawer EB; Laing I; Gokal R
Nephron; 1996; 72(1):52-8. PubMed ID: 8903861
[TBL] [Abstract][Full Text] [Related]
5. Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate- and bicarbonate-buffered peritoneal dialysis solutions.
Fourtounas C; Savidaki E; Roumelioti M; Dousdampanis P; Hardalias A; Kalliakmani P; Papachristou E; Drakopoulos A; Goumenos DS; Vlachojannis JG
Adv Perit Dial; 2006; 22():187-91. PubMed ID: 16983967
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. Low calcium peritoneal dialysis solution. Effects on calcium metabolism and bone disease in CAPD patients.
Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Santoni O; Pietrucci A
ASAIO J; 1992; 38(3):M593-5. PubMed ID: 1457929
[TBL] [Abstract][Full Text] [Related]
8. Reversibility of parathyroid gland suppression in CAPD patients with low i-PTH levels.
Montenegro J; Saracho R; González O; Moina I; Martínez I
Clin Nephrol; 1997 Dec; 48(6):359-63. PubMed ID: 9438094
[TBL] [Abstract][Full Text] [Related]
9. Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis.
Montenegro J; Saracho R; Gallardo I; Martínez I; Muñoz R; Quintanilla N
Nephrol Dial Transplant; 2007 Jun; 22(6):1703-8. PubMed ID: 17405794
[TBL] [Abstract][Full Text] [Related]
10. The requirement of low calcium dialysate in patients on continuous ambulatory peritoneal dialysis receiving calcium carbonate as a phosphate binder.
Cheng IK; Lu HB; Chan CY; Cheng SW; Robinson JD; Tam SC; Lo WK; Cheung WC
Clin Nephrol; 1993 Aug; 40(2):100-5. PubMed ID: 8222365
[TBL] [Abstract][Full Text] [Related]
11. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of serum ionized magnesium in patients receiving hemodialysis or peritoneal dialysis.
Markell MS; Altura BT; Sarn Y; Delano BG; Ifudu O; Friedman EA; Altura BM
ASAIO J; 1993; 39(3):M801-4. PubMed ID: 8268649
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC
Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
[TBL] [Abstract][Full Text] [Related]
14. [Replacement of aluminum-containing phosphate binders by calcium and magnesium carbonates in long-term hemodialysis].
Zellweger U; Zaugg PY; Dambacher M; Binswanger U; Gautschi K; Hany A
Dtsch Med Wochenschr; 1989 Apr; 114(17):659-64. PubMed ID: 2707134
[TBL] [Abstract][Full Text] [Related]
15. [The effect of the number of peritonitis episodes on peritoneal membrane function].
Jovanović D; Nesić V; Dimitrijević Z
Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
[TBL] [Abstract][Full Text] [Related]
16. Polyglucose dialysis solution induces changes in blood chemistry.
Grzegorzewska AE; Antczak-Jedrzejczak D; Leander M; Mariak I
Adv Perit Dial; 2001; 17():101-8. PubMed ID: 11510254
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of an optimized 1.1% amino-acid solution for peritoneal dialysis.
Faller B; Aparicio M; Faict D; De Vos C; de Précigout V; Larroumet N; Guiberteau R; Jones M; Peluso F
Nephrol Dial Transplant; 1995; 10(8):1432-7. PubMed ID: 8538938
[TBL] [Abstract][Full Text] [Related]
18. Calcium alginate, an aluminum-free phosphate binder, in patients on CAPD.
Passlick J; Wilhelm M; Busch T; Grabensee B; Ohnesorge FK
Clin Nephrol; 1989 Aug; 32(2):96-100. PubMed ID: 2766587
[TBL] [Abstract][Full Text] [Related]
19. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
20. Inverse correlation between serum magnesium and parathyroid hormone in peritoneal dialysis patients: a contributing factor to adynamic bone disease?
Wei M; Esbaei K; Bargman JM; Oreopoulos DG
Int Urol Nephrol; 2006; 38(2):317-22. PubMed ID: 16868704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]